Dose term in the ANOVA Model [Regulatives / Guidelines]

posted by balakotu – India, 2019-06-21 07:31  – Posting: # 20354
Views: 799

» » As per the FDA guidance of Sapropterin Dihydrochloride Tablets, The total dose should be included in the ANOVA model.
»
» I believe they meant to do an ANCOVA with total dose as covariate.
» Your (fixed) factors would be subject, sequence, period, treatment. Note that even with the bogus random statement in SAS when using PROC GLM the model is fit with a single random term (the 'error').

Dear ElMaestro,

Thaks for your response.

When i keep totaldose is a factor along with normal fixed effects (seq sub(seq) per trt) the model is not execute, Please let us know what are the fixed effects is required in ANOVA model.

SAS code:
model Cmax AUCt AUCi= seq sub(seq) per trt totaldose / ss3;
test h= seq e=sub(seq)/htype=3 etype=3;


Regards
Kotu.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,889 posts in 4,215 threads, 1,364 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 08:10 CEST

I have no opinion about ‘incurred samples’ –
an expression which has no easily understandable
meaning for me in the English language.    Nick Holford

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5